JUNE 25, 2021

Oryn Therapeutics has opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial (“A Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs”). The details of the study can be found at:

https://clinicaltrials.gov/ct2/show/NCT04286789?spons=Oryn+Therapeutics&draw=2&rank=2

A Phase 1a clinical trial study was successfully completed in 2020.